Project Oncology®
By ReachMD
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by ReachMD
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 19
Reviews: 0
Episodes: 178
Description
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
| Episode | Date |
|---|---|
|
Addressing Barriers to CAR T Referral in R/R LBCL
|
May 15, 2026 |
|
ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
|
May 15, 2026 |
|
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
|
May 08, 2026 |
|
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
|
Apr 30, 2026 |
|
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
|
Apr 30, 2026 |
|
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
|
Apr 30, 2026 |
|
Combatting Challenges & Health Disparities in Colorectal Cancer Care
|
Apr 30, 2026 |
|
ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
|
Apr 09, 2026 |
|
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
|
Feb 13, 2026 |
|
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
|
Feb 12, 2026 |
|
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
|
Jan 30, 2026 |
|
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
|
Jan 29, 2026 |
|
Advancing HER2-Targeted Therapy in GI Cancers
|
Jan 20, 2026 |
|
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
|
Jan 16, 2026 |
|
How AI Is Transforming Biomarker Development in GI Oncology
|
Jan 16, 2026 |
|
ctDNA-Guided Immunotherapy Shows Survival Benefit in MIBC: IMvigor011 Results
|
Dec 23, 2025 |
|
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
|
Dec 22, 2025 |
|
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
|
Dec 22, 2025 |
|
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
|
Dec 16, 2025 |
|
Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
|
Dec 10, 2025 |
|
Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
|
Dec 10, 2025 |
|
Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity
|
Dec 10, 2025 |
|
Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
|
Dec 09, 2025 |
|
Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
|
Dec 09, 2025 |
|
CLL17 Trial Insights: Fixed-Duration vs Continuous Therapy in Frontline CLL
|
Dec 08, 2025 |
|
Modernizing Pulmonary Assessment: Reassessing Race-Neutral Interpretation in Practice
|
Oct 21, 2025 |
|
Reevaluating Race in Spirometry: Advancing Equity in Pulmonary Risk Assessment
|
Oct 21, 2025 |
|
Advancing Precision Medicine in NSCLC: Real-World Impact of the PREDICT Initiative
|
Oct 09, 2025 |
|
Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
|
Oct 01, 2025 |
|
Evaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers
|
Oct 01, 2025 |
|
CRISPR in Sickle Cell: Transforming Care Through Gene Editing
|
Oct 01, 2025 |
|
Advances in Disease-Modifying and Curative Therapies for Sickle Cell Disease
|
Oct 01, 2025 |
|
Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care
|
Sep 18, 2025 |
|
Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
|
Sep 17, 2025 |
|
Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
|
Sep 16, 2025 |
|
Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
|
Sep 15, 2025 |
|
Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
|
Sep 10, 2025 |
|
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
|
Sep 09, 2025 |
|
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
|
Sep 09, 2025 |
|
The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
|
Sep 09, 2025 |
|
Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
|
Sep 09, 2025 |
|
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
|
Aug 19, 2025 |
|
Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
|
Aug 06, 2025 |
|
Pediatric Sickle Cell Disease: Analyzing Trends in Medication Utilization
|
Jul 29, 2025 |
|
Sickle Cell Disease Care: Balancing Disease-Modifying and Curative Therapies
|
Jul 22, 2025 |
|
Sickle Cell Disease Care: Examining Hydroxyurea and Chronic Transfusions
|
Jul 21, 2025 |
|
The Transition from Pediatric to Adult Care for Patients with Sickle Cell Disease
|
Jul 21, 2025 |
|
Balancing Benefits and Risks in Emerging Sickle Cell Therapies
|
Jul 21, 2025 |
|
Cardiac Complications in Sickle Cell Disease: Emerging Evidence and Risks
|
Jul 21, 2025 |
|
Subcutaneous Cancer Immunotherapy at Home: Transforming Trials and Patient Care
|
Jun 10, 2025 |
|
Unpacking the Logistics of At-Home Subcutaneous Cancer Immunotherapy Delivery
|
Jun 05, 2025 |
|
Bringing Cancer Care Home: How Subcutaneous Immunotherapy Can Help Ease the Burden
|
Jun 05, 2025 |
|
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
|
Jun 03, 2025 |
|
Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies
|
Apr 07, 2025 |
|
The Future of ITP Care: Exploring New Treatments
|
Dec 16, 2024 |
|
Understanding iMCD Through RNA Sequencing
|
Dec 16, 2024 |
|
Understanding Heparin Resistance: Underlying Mechanisms and Alternative Treatment Options
|
Dec 16, 2024 |
|
Diagnosing Castleman Disease: Key Considerations
|
Dec 10, 2024 |
|
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
|
Dec 09, 2024 |
|
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
|
Sep 16, 2024 |
|
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
|
Jul 30, 2024 |
|
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
|
Jul 29, 2024 |
|
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
|
Jul 23, 2024 |
|
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
|
Jul 16, 2024 |
|
Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection
|
Jul 09, 2024 |
|
Current Updates in Brain Imaging and Neurodegenerative Diseases
|
Jul 09, 2024 |
|
Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis
|
Jul 03, 2024 |
|
A Look at the Utility of PSMA PET Scans in Prostate Cancer
|
Jul 01, 2024 |
|
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
|
Jul 01, 2024 |
|
Highlighting the Current Status and Future of Theranostics
|
Jun 28, 2024 |
|
AI in Nuclear Medicine: Improvements in the Field
|
Jun 28, 2024 |
|
The Evolving AI Landscape in Nuclear Medicine
|
Jun 28, 2024 |
|
Diving into New Directions of Radiopharmaceuticals
|
Jun 28, 2024 |
|
A Unique Look at the Current and Future Directions of Cancer Vaccines
|
Jun 20, 2024 |
|
A Look at the Horizon of Cancer Vaccines
|
Jun 20, 2024 |
|
The Impact of Advocacy on Healthcare
|
Jun 14, 2024 |
|
The Power of Patient Advocacy in Daily Clinical Practice
|
Jun 14, 2024 |
|
Updates on New Technologies and Imaging Agents in Healthcare
|
Jun 14, 2024 |
|
Maximizing B-Cell Lymphoma Outcomes with CAR T-Cell Therapy and Personalized Care
|
Apr 04, 2024 |
|
Managing B-Cell Lymphomas in the Second-Line Setting: The Role of CAR T-Cell Therapy
|
Apr 04, 2024 |
|
Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
|
Mar 13, 2024 |
|
mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib
|
Feb 20, 2024 |
|
Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access
|
Feb 15, 2024 |
|
Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification
|
Feb 09, 2024 |
|
Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
|
Feb 09, 2024 |
|
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
|
Jan 29, 2024 |
|
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
|
Jan 25, 2024 |
|
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
|
Jan 25, 2024 |
|
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
|
Jan 25, 2024 |
|
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
|
Dec 28, 2023 |
|
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
|
Dec 21, 2023 |
|
Inflammatory Breast Cancer: A New Scoring System Proposed
|
Dec 21, 2023 |
|
A Look at What’s New in Invasive Lobular Carcinoma
|
Dec 08, 2023 |
|
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
|
Nov 06, 2023 |
|
Examining the Economic Impacts of Biosimilars in Oncology
|
Nov 01, 2023 |
|
Approaches to Utilizing Bone-targeting Therapies in mBC
|
Sep 15, 2023 |
|
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
|
Sep 06, 2023 |
|
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
|
Sep 05, 2023 |
|
Diving into the Efficacy & Tolerability of mBC Treatment
|
Aug 15, 2023 |
|
Reducing the Rise of Uterine Cancer in the United States
|
Jul 17, 2023 |
|
Investigating a Therapy for Brain Metastases: A Growing Problem
|
Jul 03, 2023 |
|
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
|
Jun 13, 2023 |
|
Impact of Infertility & Elective Fertility Among Female Oncologists
|
Jun 09, 2023 |
|
Combating the Complexities of Cancer Care During Pregnancy
|
Jun 07, 2023 |
|
Optimizing Quality & Safety Systems to Reduce the Risk of Patient Harm
|
May 30, 2023 |
|
Managing Immunotherapy Toxicities in Lung Cancer Patients
|
May 22, 2023 |
|
Exploring the Role of Biomarkers in Lung Cancer Treatment
|
Apr 25, 2023 |
|
Key Insights on Screening for HPV-Positive Oropharynx Cancer
|
Apr 10, 2023 |
|
Exploring Fungi in Cancer-Type Tumors & Cancer Therapeutics
|
Jan 10, 2023 |
|
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
|
Oct 28, 2022 |
|
Recognizing the Role of Capmatinib for METex14 in NSCLC
|
Oct 13, 2022 |
|
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
|
Aug 16, 2022 |
|
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
|
Jul 25, 2022 |
|
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
|
Jul 13, 2022 |
|
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
|
Jun 28, 2022 |
|
Treating Metastatic Breast Cancer: Where Are We Now?
|
Jun 27, 2022 |
|
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
|
Jun 24, 2022 |
|
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients
|
Jun 21, 2022 |
|
Conversations Around Chemotherapy: Do All of Your Patients Need It?
|
May 13, 2022 |
|
Combatting Breast Cancer with Chemoprevention
|
May 05, 2022 |
|
A Look at the Therapeutic Landscape for Metastatic Breast Cancer
|
Apr 15, 2022 |
|
Exploring the Treatment Landscape for Triple-Negative Breast Cancer
|
Apr 15, 2022 |
|
Hepatocellular Carcinoma: Evaluating the Evolving Treatment Landscape
|
Mar 24, 2022 |
|
Closing the Gaps in Cancer Screening: Insights from the President's Cancer Panel
|
Mar 17, 2022 |
|
Anesthesia Technique & Cancer Recurrence: What Do We Need to Know?
|
Feb 28, 2022 |
|
Fighting Multiple Myeloma with Triplet Therapy
|
Jan 19, 2022 |
|
Pediatric Oncofertility: Key Considerations & Procedures
|
Jan 12, 2022 |
|
A Global View of Oncofertility: Lessons Learned from Around the World
|
Jan 12, 2022 |
|
Survivorship Care for Breast Cancer Patients: Exploring the Role of the Primary Care Physician
|
Jan 03, 2022 |
|
A Look at the Emerging Field of Oncofertility
|
Dec 20, 2021 |
|
Head & Neck Cancer Updates from ESMO 2021
|
Nov 29, 2021 |
|
Exploring Therapeutic Updates for Lymphoma
|
Nov 23, 2021 |
|
Checkpoint Inhibitor Combination Therapy for First-Line Advanced NSCLC
|
Sep 13, 2021 |
|
Aiding Decision-Making with Artificial Intelligence
|
Sep 03, 2021 |
|
Clearing Up Non-Clear Cell Renal Cell Carcinoma Management
|
Aug 05, 2021 |
|
Serving the Underserved: The Role of CT Scans in Lung Cancer Screening
|
Aug 03, 2021 |
|
Exploring Advances in Treatment: A Step Forward in Small Cell Lung Cancer
|
Jun 09, 2021 |
|
Evaluating Biomarkers at Work in NSCLC
|
May 25, 2021 |
|
Investigating Immunotherapy & Its Role in NSCLC
|
May 25, 2021 |
|
Reacting to RET Inhibitors: A Look at Progression & the Future
|
May 04, 2021 |
|
Concerning Kinases: Therapeutic Considerations for RET Rearranged NSCLC
|
May 04, 2021 |
|
ASCO Investigates Disparities in Cancer Care: Representation in Oncology
|
Apr 23, 2021 |
|
Assessing Quality of Care: Implementing a Lung Screening Program
|
Apr 16, 2021 |
|
Understanding Updates in Lung Cancer Screening
|
Apr 16, 2021 |
|
Exploring Early-Stage Mesothelioma: What Are the Latest Treatment Approaches?
|
Apr 01, 2021 |
|
A Step-by-Step Approach to Managing Mesothelioma
|
Mar 24, 2021 |
|
Exploring EGFR Mutations in Lung Cancer: Key Diagnostic & Management Strategies
|
Mar 18, 2021 |
|
Examining Genomic Testing & Targeted Therapies in Lung Cancer
|
Mar 02, 2021 |
|
Communities Conquering Cancer: Exploring Global Oncology Trends
|
Mar 01, 2021 |
|
Collaborating for a Cure: Emerging Studies & the Future of Oncology
|
Mar 01, 2021 |
|
An Oncologist's View: Cancer Care & Self Care During Winter
|
Jan 22, 2021 |
|
Cancer Care During the COVID-19 Pandemic
|
Jan 22, 2021 |
|
Confronting the Disparity Crisis in Breast Cancer Care
|
Jan 15, 2021 |
|
Systemic Racism & Disparities in Oncology
|
Jan 12, 2021 |
|
Exploring the Impacts of Race & Bias in Cancer Treatment
|
Jan 12, 2021 |
|
Assessing Advancements in Treatment Options for Small Cell Lung Cancer
|
Jan 06, 2021 |
|
How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care
|
Dec 23, 2020 |
|
Exploring the Treatment Landscape for Head & Neck Cancer
|
Dec 23, 2020 |
|
The COVID-19 Pandemic & Dangerous Delays in Cancer Screenings
|
Dec 21, 2020 |
|
HIPEC: A Novel Treatment for Advanced Abdominal Cancers
|
Jan 23, 2020 |
|
Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer
|
Feb 19, 2018 |
|
What to Know About a State-of-the-Art Approach to GIST Treatment
|
Jan 17, 2018 |
|
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
|
Jan 07, 2018 |
|
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
|
Oct 23, 2017 |
|
Pancreatic Cancer: The Hunt to Catch a Silent Killer
|
Aug 12, 2017 |
|
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
|
Jul 28, 2017 |
|
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
|
Jul 25, 2017 |
|
Linking p53 Variation to Breast Cancer Risk in African American Women
|
Jun 19, 2017 |
|
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
|
May 30, 2017 |
|
Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
|
May 23, 2017 |
|
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
|
May 22, 2017 |
|
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
|
May 18, 2017 |
|
Hot Topics in Breast Cancer Innovations
|
Feb 06, 2017 |
|
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient
|
Feb 02, 2017 |
|
High Hopes for Cannabis in Oncology: Therapeutic Applications Beyond Pain Management
|
Apr 20, 2016 |
|
From Silent Killer to Treatable Disease: Improved Detection Methods for Ovarian Cancer
|
Mar 07, 2016 |
|
Are Practicing Ob-Gyn Oncologists on Your Speed Dial?
|
Feb 08, 2016 |
|
Nutrition & Breast Cancer Risk: Connecting the Dots with Emerging Evidence
|
Aug 31, 2015 |